← Home / SeaStar Medical Holding Corp (ICU)
Stock Analysis

SeaStar Medical Holding Corp (ICU)

ICU
ICU · Healthcare • Biotechnology
3.14 -2.18%
Track ICU in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ICU price is:
52W Range Position
9%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-26 21:18 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Strong / Negative / Pressured / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
2.93
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
12
●
Financial Results
HIGH
ICU reports financial results
On August 12, 2026, the Company issued a press release announcing its financial condition and results of operations for the three and six months ended June 30, 2026.
8-K Filing • SEC EDGAR
JUL
1
●
Management / Board
MEDIUM
ICU board and management update
Executives will receive an additional amount equal to 25% of each payment in shares of the Company’s common stock under the Company’s 2022 Omnibus Incentive Plan, with the number of shares being determined based on the share price at the close of business on each applicable vesting date.
8-K Filing • SEC EDGAR
JUN
17
●
Management / Board
MEDIUM
ICU board and management update
The annual meeting of stockholders of the Company was held virtually on June 17, 2026 at 10:00 a.m., Mountain Time.
8-K Filing • SEC EDGAR
What's Driving ICU?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is strong. Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
losing 2.93 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
40.8
Price Chart
ICU — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$14.1M
Company size
EV
$7.2M
Debt-adjusted value
P/S
8.2
Balanced
P/B
3.2
Balanced
EV/Sales
4.2
Balanced
EV/EBIT
-0.7
Not meaningful
P/FCF
-1.5
Not meaningful
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
615,000
↗ Strong
📈 Net Income
-3.73M
↘ Negative
🧮 EPS (Basic)
-0.91
↘ Negative
SeaStar Medical Holding Corp
Healthcare • Biotechnology
You Might Also Like